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Epidermal Langerhans cells (LC) 1 play a key role in the presentation of antigen to 
lymphocytes during the induction of delayed contact hypersensitivity (1-5). Normal 
functioning of the epidermal LC  therefore may be a  prerequisite for the induction 
and elicitation of contact allergic reactions. Recently, UVB light  (10 mJ/cm  ~ once 
daily  for  4  consecutive  d)  has  been  reported  to  diminish  the  density  of murine 
epidermal LC as determined by staining for membrane ATPase (6, 7) and to prevent 
the induction of contact sensitization to dinitrofluorobenzene (6). Furthermore, when 
such  irradiation  is  administered  in  higher  doses  (720  mJ/cm  2 thrice  weekly for 4 
consecutive wk)  even  spleen  cells  from  such  UVB  irradiated  mice  are  unable  to 
present antigens effectively (8). It was therefore of great interest to ascertain whether 
other  physicochemical  agents  also  have  an  effect on  the  number  or  functions  of 
epidermal LC. 
Glucocorticosteroids are the agents most commonly used for the treatment of skin 
diseases. We therefore investigated the effect of these agents on the LC. Burrows and 
Stoughton  (9)  reported inhibition of the induction of contact sensitivity to dinitro- 
chlorobenzene (DNCB)  in  human  skin  by the simultaneous  application  of topical 
glucocorticoids; however, the possible role of epidermal LC in mediating this effect 
was not examined. 
The present study was undertaken to determine the effect of repeated topical and 
systemic administration of glucocorticoids on the density of epidermal LC of guinea 
pigs, as assessed by staining for cell membrane ATPase activity and Ia antigens, and 
by electron microscopy (EM).  It  will  be  shown  that  glucocorticoids of high  anti- 
inflammatory  activit);  such  as  betamethasone  diproprionate  and  betamethasone 
valerate cause a marked decrease in LC demonstrable by these methods in guinea pig 
skin. 
Materials and Methods 
Animals.  Inbred strain 13 guinea pigs were used throughout the experiments  involving the 
topical  applications  of glucocorticoids. Outbred Hartley strain guinea pigs (Camm Research 
* Supported by grants AM26091, IA 3076, and GM 07552 from the National Institutes of Health. 
To  whom  r~)print  request  should  be  addressed  at  the  Department  of  Dermatology,  New  York 
University Medical Center, 550 First Avenue, New York 10016. 
I Abbreviations  used  in  the  paper:  BD,  betamethasone dipropionate;  BV,  betamethasone valerate;  CL, 
cortisol;  CN, cortisone; EM, electron microscopy; LC, Langerhans cells; MP, methylprednisolone sodium 
succinate; NS, normal saline; TAC, triamcinolone acetonide suspension; WBC, leukocytes. 
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Lab Animals, Wayne, N. J.) were used in the studies on the effects of systemically administered 
glucocorticoids. 
Topical and Systemic Glucocorticosteroid Administration.  Guinea pigs  were locally treated with 
0.1% and 0.5% concentrations of betamethasone dipropionate (BD), betamethasone valerate 
(BV), cortisol (CL), and cortisone (CN). The drugs were prepared by dissolving  the pure steroid 
compounds  (Schering  Corp.,  Kennilworth, N.  J.)  in  absolute  ethanol.  Four  3  em  2 areas 
separated by 2 cm were mapped out on the dorsal surface of each guinea pig and marked with 
suture material. Twice daily, for either 14 or 21 d, one of these areas was treated with 0.05 ml 
of either one of the above steroid solutions, ethanol, or saline; the fourth area was left untreated. 
During the treatment period, two 6 mm punch biopsies were performed from each treatment 
and control area on days 0,  2, 4,  7,  10, and  14, and where applicable, on days  17  and 21. 
Biopsies were likewise obtained on days 2, 4, and 7 after treatment had been discontinued. 
Periodically, during and after treatment, biopsies were taken for EM. At the beginning  of each 
experiment and at the time of each biopsy, the guinea pigs were shaved with an electric clipper. 
The remaining hair was then removed with Neet (Whitehall Laboratories Inc., New York). 
Systemic glucocorticoid treatment was accomplished by intraperitoneal injections once daily 
for  5 consecutive d  of 100 mg/kg,  10 mg/kg, or  1 mg/kg of either triamcinolone acetonide 
suspension (TAC) (E. R. Squibb & Sons, Inc., Princeton, N. J.) or methylprednisolone  sodium 
succinate (MP)  (The Upjohn Co.,  Kalamazoo, Mich.) in saline. Control animals received the 
same volume of normal saline (NS) instead of the drug. Biopsies were performed on the dorsal 
skin of all animals before the first injection and on days 0,  1, 2, 4, 9,  14, and 18 on the TAC- 
treated animals. MP-treated animals were biopsied on days 0, 1, 2, 3, 4, 7, 9, and 11. Peripheral 
blood for blood counts was also obtained from the latter group by retro-orbital sinus puncture. 
Light  Microscopic Enumeration of LC.  Each biopsy was immersed in 1 M  NaBr for 3-4 h at 
room temperature. The epidermal sheets were then easily separated from the underlying  dermis. 
The epidermis was  then fixed  in 5%  neutral formalin at  20°C for  20  min and stained for 
ATPase activity or for the presence of Ia antigen as described below. The stained specimens 
were  allowed to air-dry (dermal side  up)  on cover slips  and then mounted with Permount 
(Fisher  Scientific Co., Pittsburgh, Pa.).  The density of LC within each epidermal sheet  was 
determined using a light microscope with a calibrated eyepiece  (Zeiss Kpl W125 ×  20, Carl 
Zeiss Inc., New York). The number of LC per mm  2 in one central and four peripheral areas of 
each epidermal sheet was determined; epidermal areas about the hair follicles were excluded. 
The reported LC density for each sheet  represents the arithmetic average of the five counts ± 
2  standard error per mm  of skin surface. 
A TPase and Ia Staining.  Stains for ATPase activity were performed as described by Wolff 
and Winkelmann (10). Staining for Ia-bearing epidermal cells was performed using an anti-Ia 
antiserum. This antiserum was prepared by immunizing  inbred strain 2 guinea pigs with spleen 
cells  from  inbred strain  13  animals according to the method of Shevach, et  al.  (11). Fixed 
epidermal samples were washed in 0.05 M Tris buffer in normal saline (pH 7.6) and incubated 
for 60 min at 37°C with anti-Ia antiserum. The tissue was then washed three times in the Tris 
buffer and incubated for 60 minutes at 37°C with 0.1 mg of protein A conjugated to horseradish 
peroxidase  (Zymed Laboratories, Burlingame, Calif.)  per ml of Tris buffer. The epidermal 
sheets were  again washed three times with Tris buffer and stained with 0.1  ml of a solution 
containing  0.075 g of 3,3'-diaminobenzidine  tetrachloride plus 0.1 ml of 3% H202/100 ml Tris 
buffer. The stained sheets were washed three more times with Tris buffer and allowed to air dry 
on cover slips. 
Electron Microscopy.  Biopsies taken for EM were fixed according to the method of Karnovsky 
(12) and post-fixed  in OsO4. They were then embedded in Epon and cut in 700 .~ sections, 
stained with a uranyl acetate-lead citrate mixture, and studied under a Zeiss electron microscope 
10 (Carl Zeiss Inc.). 
White Blood Count.  Counts were done using a standard hemocytometer dilution technique. 
Differential counts were performed on blood smears stained with Wright's stain. 
Statistics.  All probabilities were determined using a two- or three-way analysis of variance. 
Results 
Topically Applied Glucocorticosteroids 
ATPAsE  AND  IA  STAIN.  Both  the  0.1  and  0.5%  concentrations of BD  and  BV BELSITO  ET  AL.  293 
produced a significant (P< 0.01) decrease in LC density as determined by the number 
of ATPase positive cells, as well as by staining for Ia antigen (Figs.  1-3). The observed 
decrement  appeared to be an "all or nothing" phenomenon: there was no evidence 
that cells possessed  intermediate  densities of surface  markers.  This  decrease  became 
evident as early as 2 d after initiation of treatment with 0.5% BD. It was more readily 
demonstrated at this time with staining for ATPase  rather than for Ia.  By day 7, in 
both 0.1%  and 0.5%  BD-treated  areas, the decrease  in ATPase  and Ia positive cells 
had become  statistically significant  (P <  0.01).  The  decrease  in LC  caused  by  BV 
% 
E 
_1 
W 
O 
IJ.J 
> 
F- 
O 
n 
o 
n 
I-- 
"6 
Z 
1,600 
1,4001 
1,200 
1,ooo 
8OO 
6OO 
4OO - 
7/'~TREAT  M  E NT//~//] 
I  I  v 
0  4  8  12  16202428 
DAY 
% 
E 
(/) 
uJ 
L) 
Z 
n~ 
h, 
m 
d 
Z 
1,60C 
1,4(X: 
1,200 
1,000 
80O 
6OO 
4OO 
~..~  T R  E AT  M E N  TT///I 
DAY 
J  ~  CONTROL  [ 
O--O  TREATMENT:  0.5%  BETAMETHASONE  DJPROPIONATE 
1,600  1,600 
E 
1,400  E  1,400 
c/) 
o  1,200  jJ  1,200 
hi  hi 
>  (J 
~__  1,000  (.9  1,000 
_z 
0  n- 
o_  800  <  ,,,  800 
n  600  ~  6(}0  I- 
<  "6 
400  ~  400 
i  i  i  i  ,  ,,  ,  ,  i  r  i  i  i  i 
0  4  8  1216202428  0  4  8  I;)  16202428 
DAY  DAY 
i  H  CONTROL  l 
O--.O  TREATMENT:  O. 1 o&  BETAMETHASONE  DIPROPIONATE 
Flo.  1.  Effect  of topical BD on epidermal LC. Guinea pigs were treated twice daily for 2I  d with 
either 0.5%  (top)  or 0.1%  (bottom)  solutions  of BD  in  absolute  ethanol.  Duplicate  biopsies  were 
obtained  from dorsal skin on day 0 before treatment and on days 2, 4, 7,  10,  14,  17, and 21, as well 
as 7 d after discontinuation  of treatments.  Epidermal sheets were obtained and stained for ATPase 
activity (O, left)  and Ia antigen  (O, right). Control  values (0)  represent the arithmetic mean of the 
untreated controls, NS-treated controls, and ethanol-treated  controls ±  standard error (SE). 294  EFFECT  OF GLUCOCORTICOSTEROIDS ON  LANGERHANS CELLS 
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I"IC.  2.  Effect of topical BV on epidermal LC. Guinea pigs were treated with either 0.5'7~ (top) or 
0.1%  (bottom) solutions of BV in absolute ethanol. Biopsies were performed as described in Fig.  I. 
Epidermal sheets were obtained and stained for ATPase activity (O, left) and Ia antigen ((3), right). 
Control values (0)  represent the arithmetic mean of the untreated controls, NS-treated controls, 
and ethanol treated controls -  SE. 
developed somewhat slower and became significant only after day 7 (0.5%) or day 10 
(0.1%).  In each case, a  near  maximal  decrease  of 37-62%  in  the  density  of LC was 
noted  with  both  staining  procedures  to occur by day  14  (Figs.  1 and  2;  Table  I). 
Treatment twice daily with either drug for an additional wk produced only a minimal 
further decline in LC density.  It was noted, however, that in the animals treated  for 
21  d  with 0.5%  BD or BV, there was a  significant  decrease  (P <  0.01)  in  LC in the 
control sites,  suggesting that  by this  time sufficient systemic absorption of the drugs 
had  occurred  to  affect  untreated  sites  in  these  animals.  Increased  absorption  of BELSITO ET AL.  295 
Fxc.  3.  Photomicrographs  of ATPase stained epidermal sheets (a) before and  (b) after 21  d of 
twice daily 0.5% betamethasone dipropionate applied topically. Same specimens stained for Ia 
antigen before (c) and after (d) treatment (light microscope,  × 500). 
glucocorticoids  via the  biopsy-damaged skin  areas could  have added  to  this  effect. 
Upon discontinuation of local treatment, the LC density in both treated and control 
sites returned to pretreatment levels within  7 d  as measured by both criteria (Figs.  I, 
2  and  4).  Double  blind  studies  (Table  II,  guinea  pigs  1  and  2)  reaffirmed  these 
findings for animals treated with a 0.1% BD solution. 
Application  of 0.5%  CL  and  0.5%  CN  produced  a  slight  decline  (30  and  22%, 
respectively)  in  LC  density  (Tables  I  and  III)  as  determined  by  ATPase  stain; 
however, these decrements were barely significant  (P <  0.05).  No diminution of cells 
by Ia staining was noted with either drug (Tables I and III). In double blind studies 
using  0.5%  CL,  the  previously  found  decrement  in  LC  density  was  not  observed 
(Table  II, guinea  pigs  3  and  4).  Topical  application  of CL,  0.1%,  and  CN,  0.1%, 
solutions had no effect (data not shown). 
EM  STUDIES.  Ultrastructural  examination of the skin  from animals treated topi- 
cally  with  BD  in  either  0.5  or  0.1%  concentrations  showed  alterations  in  the  LC 
starting on day 4 that became maximal by day 7. These changes affected ~50% of the 
clearly recognizable LC in any given biopsy. Alterations noted included clumping of 
nuclear chromatin, dilatation of endoplasmic reticulum, swelling and condensation of 
mitochondria  with  flocculent  densities,  and  myelin  figures  (Fig.  5).  No  alterations 296  EFFECT OF GLUCOCORTICOSTEROIDS  ON  LANGERHANS CELLS 
TABLE  I 
Effect of Topical Glucocorticoids on Epidermal LC Membrane Markers 
Applied drug  Drug 
concentration 
Percent decrease in LC density on 
day 14 of treatment 
By ATPase  By staining for la 
staining  antigen 
BD  0.5%  62*  48* 
0.1%  52*  44* 
BV  0.5%  53*  40* 
0.1%  40*  37* 
CL  0.5%  305  0 
0.1%  0  0 
CN  0.5%  22:}:  0 
0.1%  0  0 
* P vs. control < 0.01. 
P vs. control < 0.05. 
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FIC. 4.  Effect of topical BD on Ia-bearing epidermal LC. Guinea pigs were treated twice daily for 
7 d with either 0.5% ([]) or 0.1% ([]) BD. Punch biopsies  were obtained before beginning treatment 
on day 0 and on day 7 of treatment as well as days 4 and 7 after treatments were discontinued. 
Epidermal sheets were obtained and stained for Ia antigen. Controls (O) represent the arithmetic 
mean of untreated and ethanol treated animals + SE. 
were  noted  in the  keratinocytes.  By  day  7  after  cessation of topical  steroids  these 
changes could no longer be seen.  The  findings were  similar to  those  seen in other 
forms of cell injury, such as those caused by ischemia (13). 
Systemically  Administered Steroids.  Guinea pigs were  given five daily intraperitoneal 
injections of TAC at  10 mg/kg and  100 mg/kg (Fig. 6). 5 d  after discontinuation of 
treatment, there was a  49%  (100 mg/kg, P  <  0.01)  and a  28%  (10 mg/kg, P  <  0.05) 
decrease in LC density. The cell density returned to baseline values within 9 d  after 
its nadir. When TAC was injected at  1 mg/kg, it did not produce any effect on the 
number of LC per mm  2 (Fig. 6). 
MP,  100 mg/kg, administered intraperitoneally, produced a  significant decline in 
the  LC  density by the  last  day  of treatment  (P <  0.01,  Fig.  7).  Within  7  d  after 
treatment was discontinued, the LC density had returned to control values. Neither 
MP  at  10  mg/kg  (Fig.  7),  1 mg/kg,  nor NS  (data  not shown)  had  any noticeable 
effect  on  LC  density.  None  of the  MP  dosage  used  had  any significant effect  on BELSITO  ET  AL.  297 
TASt.E II 
Decrease and Recovery of ATPase Positive LC in Epidermis of Guinea Pigs during and after Topical 
Treatment with O. 1% BD and 0.5% CL* 
Number of ATPaseposltive epidermal l.C/mnl~+SE 
Day of 
Treat-  Guinea pig I  Guinea pig 2  Guinea pig 3  Guinea pig 4 
ment 
Ethanol  0.1% BI):~  Ethanol  0.1'7` BI)'~  Ethanol  0.5'7, CI,:~  Ethanol  0.5'/, CI,:~ 
0  1205 ~  35  NI~  1314 ± 59  N1)  1152 ± 27  N1)  1410 ± 45  ND 
7  1252±41  586~34  1348~ 157  729±36  1114±39  971 ± 38  1310~ 111  1438±49 
10  1124 ±60  500± 31  1348 ± 47  590± 20  1019 ± 21  924 ~ 48  1038 ± 55  1338 ± 45 
1411  1124 ~1~  500~ 27  1286 ±  79  552 ± 25  990± 42  1071 ~  85  1143 ~  I10  1257 ± 95 
18  1000±46  667 ± 20  1143 ± 54  643 ± 27  1090± 44  1186 ±94  1229 ± 44  ll~) ± 43 
21  1086± 74  1143±23  1052±23  995±31  967±34  1019±46  1271 ± 60  1510± 104 
* Double blind studies. 
:~ Guinea pigs were treated topically twice daily for 14 d with the indicated drug dissolved in absolute ethanol. Control sites were painted with 
equal amounts of absolute ethanol or were left untreated. Untreated controls did not differ from the ethanol treated controls. 
§ Not done. 
II Treatments discontinued on day 14. 
TABLE III 
Effect of Topically Administered CL and CN on Epidermal LC 
Number of LC/mm 2 ±  SE as assessed by staining for 
Day of treat- 
ATPase  la antigen 
ment 
Control*  0.5% CL:]:  0.5% CN~:  Control*  0.5% CL~:  0.5%  CN:I: 
0  1290 +  53  ND§  ND  1604 ±  44  ND  ND 
4  1230 +  37  1467 +  100  1438 ::t: 39  1434 +  27  1376 +  37  1566'± 42 
10  1124±29  881±51  976::t:20  1472+29  1195-1-20  1414-+-53 
14  1152:1:: 28  962 +  50  1 124 +  64  1469 +  43  1461  ::t:  65  1585 ±  53 
21  1046 +  25  886 +  30  1024 ±  31  1403 ±  27  1395 ±  46  1528 ±  50 
* Average  of all  counts  for  that  day  on  the  untreated  controls  as  well  as  the  NS  and  ethanol  treated 
controls. 
Guinea  pigs  were  treated  topically  twice  daily  for  21  d  with  the  indicated  drug  dissolved  in  absolute 
ethanol. Control sites were painted with equal amounts of NS or absolute ethanol, or were left untreated. 
§  Not done. 
leukocyte  (WBC)  counts (Fig.  7)  or lymphocyte counts, which ranged from  55-70% 
of the total WBC count. 
Discussion 
Both topical and systemic administration of potent glucocorticosteroids resulted in 
a  decreased  density  of  LC  as  assessed  by  staining  for  ATPase  and  Ia  antigen. 
Furthermore, the decreases obtained in LC density correlated with the concentration 
and known vasoconstrictive  potency of the drugs used.  Topically,  BD proved to be 
more  rapid-acting and to result  in a  greater  decrease  in LC  density than the other 
drugs;  BV, CL, and CN  followed in decreasing order.  Systemically,  at  doses of  100 
mg/kg,  TAC  and  MP  each  caused  an  -40%  decrease  in  LC  density.  The  delayed 
action of TAC as compared with MP was to be expected in view of the relatively low 
water solubility of this drug. 
The exact mechanism  for the observed decrease  in LC density is not clear, but at 
least  three  different  possibilities  should  be  considered.  First,  there  may  have  been 298  EFFECT  OF  GLUCOCORTICOSTEROIDS  ON  LANGERHANS  CELLS 
FIG.  5.  Electronmicrographs taken on day  7 of topical treatment of guinea pig epidermis with 
0.~% BD or absolute ethanol. (a)  Normal appearing LC with Birbeck granule (---~) taken from an 
ethanol-treated control site (×  10,000). (b, c)  LC from animals treated with 0.1% BD showing (b) 
slight and (c) moderate damage.  Dilated and condensed mitochondria (11,-), phagolysosomes (~), 
and condensed nuclear chromatin were noted in ~50% of the LC. No alterations in the keratinocytes 
were observed. (----~) indicates the characteristic Birbeck granules (b, ×  18,000; c, ×  10,000). 
irreversible  damage  and  an  actual  decrease  in  number  through  cellular  death.  A 
second  possibility is that  the cells were affected  functionally as a  result of alterations 
in membrane  surface antigen and enzyme expression. Although  no direct enumeration 
of  LC  was  attempted  by  EM,  the  type  of  damage  seen  ultrastructurally  did  not BELSITO  ET AL.  299 
E  1,400 
1,200 
w  1,  000~ 
> 
~  8OO 
g. 
"6 
1  mg/kg 
6OO 
4OO 
i  t  i  i 
0  4  8  12  16 20 
DAY  i  t  i  [  [ 
0  4  8121620 
DAY 
0  4  8121620 
DAY 
F~c. 6.  Effect  of systemic TAC on epidermal LC. Animals were injected  intraperitoneally once 
daily for 5 consecutive d with either 1 mg/kg (left), 10 mg/kg (center), or 100 mg/kg (right) of the 
drug. Biopsies were taken from the dorsal skin of each animal before the first injection on day 0 and 
on days 2, 4, 9, 14, and 18. Epidermal sheets were obtained and stained for ATPase activity. 
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FIG.  7.  Effect of systemic MP on epidermal LC and peripheral WBC counts. Guinea pigs were 
injected intraperitoneally once daily for 5 consecutive d with either 10 mg/kg (left) or 100 mg/kg 
(right) of the drug. Biopsies were taken from the dorsal skin before the first injection on day 0 and 
on days 2, 4, 7, 9, and 11. Epidermal sheets were obtained and stained for ATPase activity (C)). 
Blood for WBC counts (&) was obtained on days 0, 2, 4, and 7. 
exclude reversibility of the damage  (13). Changes in function without clear cytolytic 
effect  have been described in guinea pig macrophages  in the presence of glucocorti- 
costeroids:  both  macrophage  inhibition  factor  (14)  and  macrophage  aggregation 
factor  (15)  are  inhibited  from  acting  on  the  macrophages.  Furthermore,  human 
monocytes have  been  found  to  express  reduced  rosette  formation with  erythrocytes 
coated with C3 or IgG, although phagocytosis of latex particles was unimpaired (16). 
In view of the similarities previously summarized between LC and macrophages  (I 7), 
a  functional  rather  than  killing effect  of  glucocorticosteroids  on  LC  is  a  distinct 
possiblity. The recently reported  studies of Lynch et al.  (18)  on the effects of topical 
glucocorticoids on the induction of contact sensitivity in mice suggest that  the effect 
on LC  is accompanied by functional impairment.  Finally, it  is possible that  such  a 
functional effect  could also  be the result of an enhanced migration of LC  from  the 300  EFFECT  OF GLUCOCORTICOSTEROIDS ON  LANGERHANS CELLS 
epidermis, similar to what has been observed during contact sensitivity reactions (19, 
20). The observation that the epidermis was repopulated with LC 7 d after the peak 
effect of local and systemic treatments does not help to clarify this issue;  therefore, 
further studies are being conducted. 
It was somewhat puzzling that the rapid decrease in LC seen over the first  10 d of 
topically applied glucocorticoids was  followed by a  relative plateau  on LC  density 
during  which  no  further  major  decrease  was  observed  over  the  ensuing  10  d  of 
treatment. Several possibilities, although not mutually exclusive, should be considered. 
A continuous influx of LC from the bone marrow (21) could establish an equilibrium 
with  the  damage  inflicted by the steroids.  It  is  also possible  that  two distinct  LC: 
populations exist in relation to steroid sensitivity. One of these cell populations might 
include the indeterminate dendritic cells that are thought to represent immature LC 
containing few or no characteristic Birbeck granules (22,  23).  It has been shown that 
mouse  macrophages  express  low  and  high  affinity  receptors  for  glucocorticoids, 
although there is no evidence that such receptors are expressed differently on different 
cell populations (24). Finally, the possibility that the observed equilibrium is a result 
of the kinetics of drug accumulation in the skin cannot be excluded at this time. 
As  in  man,  lymphoid cells in guinea pigs are known to be relatively resistant  to 
systemic steroid administration, although a decrease in circulating mononuclear cells 
can  be  obtained  (25-27).  In  our  experiments,  the  glucocorticosteroid doses  that 
produced  a  marked  decrease  in  LC  did  not  affect  the  peripheral  WBC  count, 
suggesting that in this system the LC is more sensitive to glucocorticosteroids than is 
the lymphocyte. 
Early reports on the effect of glucocorticoids on the immune response have suggested 
that  their major effect is  on  the  presentation  of antigen  rather  than  on  antibody 
production  (28).  LC  have  been  shown  to  serve  as  antigen-presenting  cells  in  the 
induction of antigen-specific proliferation (1-5). The effect of glucocorticosteroids on 
LC shown in this report is therefore in agreement with the conclusions of previous 
investigators. The observations that such disparate therapeutic modalities of treatment 
as ultraviolet light and glucocorticoids can prevent the induction of contact sensitivity, 
together  with  the  fact  that  both  agents  have  a  negative  effect  on  LC  activity, 
strengthen  the  hypothesis  that  the  LC  is  essential  for  the  induction  of contact 
sensitivity to environmental agents.  Furthermore, these data suggest  that  the anti- 
inflammatory action of glucorcorticosteroids in dermatologic disorders may, at least 
in part, be through the drug's ability to alter epidermal LC. 
Summary 
The effects of topical and systemic administration of various glucocorticoids on the 
density of epidermal Langerhans cells (LC) were studied in guinea pigs. Glucocorti- 
colds, such as betamethasone dipropionate and valerate, caused a marked decrease in 
LC demonstrable by staining for cell membrane ATPase activity and Ia antigens. By 
electronmicroscopy, LC  also  showed morphologic alterations.  The observed decre- 
ments in LC density correlated with the concentration and known vasoconstrictive 
potency of the glucocorticoids administered. The anti-inflammatory action of gluco- 
corticoids in skin  disorders may, at  least  in  part,  be through  their ability to alter 
epidermal LC, thus interfering with the antigen-presenting functions of these cells. BELSITO  ET AL.  301 
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